Analysts: Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

732.70INR
18 Dec 2014
Price Change (% chg)

Rs-15.50 (-2.07%)
Prev Close
Rs748.20
Open
Rs754.10
Day's High
Rs766.90
Day's Low
Rs722.80
Volume
1,212,475
Avg. Vol
754,158
52-wk High
Rs841.00
52-wk Low
Rs496.10

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- March 18 Dec 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 11 11 10 12
(2) OUTPERFORM 15 15 14 15
(3) HOLD 7 7 8 7
(4) UNDERPERFORM 2 2 2 2
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.06 1.97

Consensus Estimates Analysis

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 2 17,723.30 17,975.00 17,471.50 --
Quarter Ending Mar-15 2 19,952.00 20,285.10 19,619.00 --
Year Ending Mar-14 32 59,320.60 62,351.00 58,151.00 --
Year Ending Mar-15 32 69,602.80 72,505.50 67,337.00 70,155.00
Year Ending Mar-16 32 81,658.40 89,034.90 75,345.00 81,723.50
Earnings (per share)
Year Ending Mar-14 34 25.62 29.30 23.00 --
Year Ending Mar-15 33 30.61 35.38 27.90 32.82
Year Ending Mar-16 33 38.98 50.80 32.86 39.27
LT Growth Rate (%) 3 24.40 38.00 14.50 20.83

Historical Surprises

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-14 16,239.90 16,715.30 475.41 2.93
Quarter Ending Jun-14 14,922.80 14,778.20 144.63 0.97
Quarter Ending Mar-14 16,053.10 16,817.40 764.28 4.76
Quarter Ending Dec-13 15,616.80 16,012.20 395.42 2.53
Quarter Ending Sep-13 14,695.20 14,630.10 65.10 0.44
Earnings (per share)
Quarter Ending Sep-14 7.63 6.08 1.55 20.31
Quarter Ending Jun-14 6.20 6.81 0.61 9.75
Quarter Ending Mar-14 7.15 9.62 2.47 34.54
Quarter Ending Dec-13 6.90 7.97 1.07 15.46
Quarter Ending Sep-13 6.38 5.69 0.69 10.87

Consensus Estimates Trend

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 17,723.30 17,723.30 17,723.30 18,339.30 --
Quarter Ending Mar-15 19,952.00 19,952.00 19,952.00 20,301.00 --
Year Ending Mar-14 59,320.60 -- -- -- --
Year Ending Mar-15 69,602.80 69,602.80 69,620.00 69,760.50 70,155.00
Year Ending Mar-16 81,658.40 81,658.40 81,648.40 81,567.00 81,723.50
Earnings (per share)
Year Ending Mar-14 25.62 -- -- -- --
Year Ending Mar-15 30.61 30.61 30.72 31.73 32.82
Year Ending Mar-16 38.98 38.98 39.03 39.44 39.27

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-14 0 0 0 0
Quarter Ending Mar-15 0 0 0 0
Year Ending Mar-14 -- -- -- --
Year Ending Mar-15 0 0 0 1
Year Ending Mar-16 0 0 1 1
Earnings
Year Ending Mar-14 -- -- -- --
Year Ending Mar-15 0 0 1 1
Year Ending Mar-16 0 0 1 1

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Motilal Oswal Securities Ltd.
$81.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks